Advertisement Kendle appoints new vice president of global sales - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Kendle appoints new vice president of global sales

Kendle, a leading global clinical research organization, has appointed Mary Briggs as the new vice president of global sales. Ms Briggs will lead the ongoing sales growth strategy and develop Kendle's global sales organization.

Ms Briggs has more than two decades of sales, management and consulting experience in the biopharmaceutical industry. Since joining Kendle in 2005 as senior director of strategic accounts, Ms Briggs has developed sales growth strategies that have lead to outstanding relationships with customers and propelled her team to best-in-class sales achievement.

Simon Higginbotham, vice president and chief marketing officer of Kendle, said: “I am delighted to welcome Mary to this new and crucial role as Kendle continues to grow to meet the needs of both customers and shareholders. She has established a track record of outstanding sales leadership in the drug development industry, including significant roles within large global CROs and top biopharmaceutical companies.”